N-Acylated sulfonamide sodium salt: A prodrug of choice for the bifunctional 2-hydroxymethyl-4-(5-phenyl-3-trifluoromethyl-pyrazol-1-yl) benzenesulfonamide class of COX-2 inhibitors-Reference-Cited by-同舟云学术

N-Acylated sulfonamide sodium salt: A prodrug of choice for the bifunctional 2-hydroxymethyl-4-(5-phenyl-3-trifluoromethyl-pyrazol-1-yl) benzenesulfonamide class of COX-2 inhibitors

Published:2006-08 Issue:15 Volume:16 Page:3921-3926
ISSN:0960-894X
Container-title:Bioorganic & Medicinal Chemistry Letters
language:en
Short-container-title:Bioorganic & Medicinal Chemistry Letters

Author:

Singh Sunil Kumar,Vobbalareddy Saibaba,Kalleda Srinivasa Rao,Casturi Seshagiri Rao,Mullangi Ramesh,Ramanujam Rajagopalan,Yeleswarapu Koteswar Rao,Iqbal Javed

Publisher

Elsevier BV

Subject

Organic Chemistry,Clinical Biochemistry,Drug Discovery,Pharmaceutical Science,Molecular Biology,Molecular Medicine,Biochemistry

Reference24 articles.

1. CYCLOOXYGENASES 1 AND 2

2. Selective inhibition of prostaglandin production in inflammatory exudates and gastric mucosa

3. Mitogen-inducible prostaglandin G/H synthase: A new target for nonsteroidal antiinflammatory drugs

4. Gastrointestinal Damage Associated with the Use of Nonsteroidal Antiinflammatory Drugs

Cited by 15 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Drug/Lead Compound Hydroxymethylation as a Simple Approach to Enhance Pharmacodynamic and Pharmacokinetic Properties;Frontiers in Chemistry;2022-02-14

2. Metabolism of a 5HT6 Antagonist, 2-Methyl-1-(Phenylsulfonyl)-4-(Piperazin-1-yl)-1H-Benzo[d]imidazole (SAM-760): Impact of Sulfonamide Metabolism on Diminution of a Ketoconazole-Mediated Clinical Drug-Drug Interaction;Drug Metabolism and Disposition;2018-04-25

3. Catalytic activity of magnetic Fe3O4@Diatomite earth and acetic acid for the N-acylation of sulfonamides;Tetrahedron Letters;2016-01

4. Trifluoromethylpyrazoles as anti-inflammatory and antibacterial agents: A review;Journal of Fluorine Chemistry;2015-10

5. Preclinical in vitro and in vivo evaluation of the potent and specific cyclin-dependent kinase 2 inhibitor NU6102 and a water soluble prodrug NU6301;European Journal of Cancer;2011-09